Impact of Severe Obstructive Sleep Apnea-Hypopnea Syndrome on Auditory-Cognitive Processing
NCT ID: NCT07039500
Last Updated: 2025-08-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
100 participants
OBSERVATIONAL
2024-12-11
2025-12-10
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
1. Does severe OSAHS change how the brain automatically detects sound changes during wakefulness?
2. Does severe OSAHS reduce people's ability to pay attention to important sounds when awake?
3. Can brainwave tests (Electroencephalogram, EEG) detect early signs of hearing-related cognitive problems in OSAHS patients before symptoms appear?
Researchers will compare two groups:
* 50 adults with severe OSAHS (diagnosed by sleep tests)
* 50 healthy adults matched by age and gender
Participants will:
* Complete hearing tests (MoCA)
* Undergo a 1-night sleep test (PSG)
* Wear an EEG cap for 1.5-2 hours while listening to sounds in a quiet room:
* Passive task: Relax (no response needed)
* Active task: Press a button when hearing rare sounds
* Receive ¥75/hour compensation for their time
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Sleep Apnea, Neurocognitive Decline and Brain Imaging in Patients With Subjective or Mild Cognitive Impairment
NCT06150352
Biological and Cognitive Marker of Neurodegeneration in Obstructive Sleep Apnea Patients
NCT06167369
A Cross-sectional Study of the Occurrence and Effect of Obstructive Sleep Apnea in Subjects With Resistant Hypertension
NCT00843583
Prevalence, Phenotypes, Predictors and Prognostic Implication of Obstructive Sleep Apnea in Pulmonary Hypertension
NCT05595200
Brain Fog in Sleep Apnea
NCT06664450
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Severe OSAHS Group
Adults aged 20-60 years with severe obstructive sleep apnea-hypopnea syndrome (AHI\>30 events/hour) confirmed by polysomnography (PSG). Participants undergo PSG, hearing tests (pure-tone audiometry, tympanometry), Montreal Cognitive Assessment (MoCA), and EEG recording during active/passive auditory oddball tasks measuring MMN, P300, and behavioral responses.
No interventions assigned to this group
Healthy Control Group
Age/sex-matched healthy adults (20-60 years) with self-reported absence of snoring/sleep disorders. Participants complete hearing tests (pure-tone audiometry, tympanometry), Montreal Cognitive Assessment (MoCA), and EEG recording during identical auditory oddball tasks as the OSAHS group.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Aged 20-60 years
* Normal hearing (PTA ≤25 dB HL at 0.5,1,2,4 kHz; Type A tympanogram)
* MoCA score ≥26
* Willing to complete EEG testing
OSAHS Group Additional:
\- PSG-confirmed severe OSAHS (AHI \>30 events/hour)
Control Group Additional:
* Self-reported absence of snoring/sleep disorders
* No prior OSAHS diagnosis
Exclusion Criteria
* History of:
* Schizophrenia, epilepsy, Parkinson's, TBI, or language disorders
* Middle/inner ear diseases (otitis media, acoustic neuroma, etc.)
* Cognitive impairment or depression/anxiety disorders
* Chronic steroid use
* Systemic inflammatory diseases or malignancies
* Pregnancy or suspected pregnancy (self-reported)
20 Years
60 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Peking University First Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Peking University First Hospital
Beijing, Beijing Municipality, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PekingUFH-2024RES651-001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.